Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
SIMCERE PHARMA (HK.2096) Novel Inhibitor of COVID-19 3CLpro SIM0417 Received a Second Clinical Trial Approval in China 2022-05-18 11:56
ASEAN to build its own CDC to mitigate another pandemic risk 2022-05-18 09:00
Vela Diagnostics Launches Multiplex PCR-Based Test for Detecting UTI Pathogens and Antimicrobial Resistance Genes 2022-05-17 22:00
ASEAN accepts mutually recognized COVID-19 vaccination certificates 2022-05-17 19:14
Ascletis (1672.HK) Included in MSCI China Small Cap Index 2022-05-16 20:17
Kintor Pharma Included in MSCI China Index 2022-05-15 18:28
Seegene reports first quarter 2022 financial results 2022-05-13 19:00
NEW GUIDELINES FOR COVID TESTING 2022-05-13 17:10
Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria 2022-05-12 22:43
A novel universal antiviral drug introduced in Korea 2022-05-12 18:19
VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update 2022-05-12 04:10
Nicetown Customized Outdoor Curtains - Bring Customers New Choice 2022-05-12 01:00
Asia's first molecular diagnostics company for women, INEX Innovate receives European CE-IVD Certification for its OvaCis(R) Rapid Test to detect cancer in ovarian cysts. 2022-05-11 22:00
DetectedX Launches Radiology Online Learning Platform to the U.S. Market at SBI 2022-05-11 20:00
Prenetics and Artisan Acquisition Corp. Announce Shareholder Approval of Business Combination, To Begin Trading on Nasdaq on May 18 Under the Ticker "PRE" 2022-05-11 09:00
Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab) for Immune Restoration/Functional Cure of HIV-1 Infected Patients 2022-05-11 08:40
ProSomnus®, Leader in Patient-Preferred Sleep Apnea Therapy, to be Listed on Nasdaq Through Business Combination with Lakeshore Acquisition I Corp. 2022-05-10 20:00
U.S. Centers for Disease Control and Prevention Selects Biobot Analytics to Expand National Wastewater Monitoring 2022-05-10 00:00
Brii Bio Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Omicron BA.2 Subvariant 2022-05-09 19:46
Premix signs $79.9 million contract for a new production facility in the U.S. 2022-05-09 18:35
1 45 46 47 48 49 229